ICL670F2202: A randomized, open-label, multicenter, two arm, phase II study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload

  • Thompson, Alexis A (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/16 → 3/31/20

Funding

  • Novartis Pharmaceuticals Corporation